Hemispherx treats first patient with cancer drug Ampligen in Phase 2 clinical trials

12:15 EDT 12 Jun 2019 | Proactive Investors

The study looks at the effectiveness of ampligen in combination with the drug pembrolizumab at treating ovarian cancer

More From BioPortfolio on "Hemispherx treats first patient with cancer drug Ampligen in Phase 2 clinical trials"